Home›People›Kathleen Collins
KC

Kathleen Collins

Director at Addition Therapeutics.

Director
Updated Oct 27, 2026·Latest SEC filing Dec 22, 2025·Suggest an edit

About Kathleen Collins

Kathleen Collins is a director at Addition Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Kathleen Collins in the role, so the role may have started earlier or lasted longer.

Addition Therapeutics, Inc.
Director
2025 · South San Francisco, CA

Key Colleagues at Startups

The people Kathleen Collins works with at each company, as listed on that company's latest Form D.

Addition Therapeutics, Inc. · Form D, Dec 22, 2025
JP
PB
LK
Lawrence Kong
Secretary
JL
Jennifer Lee
Director
LS
RP
Ronald Park
Executive officer and director

Sources

  1. SECAddition Therapeutics, Inc. Form D, filed Dec 22, 2025